Global Neurostimulation Devices Market 2018-2023: Neurological Disorders is One of the Primary Factors Driving the Neurostimulation Devices Market - ResearchAndMarkets.com

May 15, 2018

DUBLIN--(BUSINESS WIRE)--May 15, 2018--The “Global Neurostimulation Devices Market - Segmented by Device Type, Application, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.

The global neurostimulation devices market is expected to register a CAGR of 12.5% during the forecast period of 2018 - 2023

The rise in the technological advancements and innovation with growing geriatric population base is increasing the demand for the need of neurostimulation devices market. The well-established healthcare infrastructure with the high adoption rate of new technologies and innovation in neurological devices, helps North America to dominate the market.

Increasing Prevalence of Neurological Disorders

The rising prevalence of neurological disorders is one of the primary factors driving the neurostimulation devices market. In 2013, as per the National Center for Health Statistics of the Centers for Disease Control and Prevention (CDC), 84,767 people had died due to Alzheimer’s disease.

Thus, a high number of patients suffering from neurological diseases needs hospitalizations, worldwide, which raises the demand for early diagnosis of these diseases driving this market.

Other factors driving this market are the rising demand for minimally invasive technologies and the expanding number of elderly patients with neurological disorders seeking technological advancements in neurological devices.

Market Dynamics


Rising Prevalence of Neurological Disorders Rising Demand of Minimally Invasive Technologies Rising Number of Elderly Patients with Neurological Disorders Development of Technologically Advanced Neurological Devices


High Cost of Neurological Diseases Treatment Lack of Skilled Healthcare Professionals in Neurology

Key Developments in the Market

February 2018 - Synergia Medical SA raised EUR 8.1 million in Series A funding for its novel opto-electronic neurostimulation device. January 2018 - Helius Medical Technologies, Inc. partnered with Key Tronic Corp. to manufacture portable neuromodulation stimulator (PoNS).

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Market Dynamics

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of the Market

11. Disclaimer

Companies Mentioned

Abbott Bayer Corporation Boston Scientific Corporation Cyberonics Inc. Depuy Synthes Interpace Diagnostics Llc Neuronetics Neuropace Inc. Nevro Corp Synapse Biomedical Inc.

For more information about this report visit https://www.researchandmarkets.com/research/pk9rq8/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180515005951/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Neurology Devices



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 05/15/2018 08:59 AM/DISC: 05/15/2018 08:59 AM


Update hourly